Citius Oncology (CTOR) Deferred Taxes (2023 - 2026)

Citius Oncology's Deferred Taxes history runs 4 years deep, the most recent figure standing at -$231210.0 for Q1 2026.

• In Q1 2026, Deferred Taxes fell 187.5% year-over-year to -$231210.0; the TTM figure through Mar 2026 stood at $561510.0 (down 55.02% YoY), while the FY2025 annual figure was $1.1 million, up 83.5% from the prior year.
• Deferred Taxes was -$231210.0 for Q1 2026 at Citius Oncology, down from $264240.0 in the prior quarter.
• In the past five years, Deferred Taxes ranged from a high of $432000.0 in Q2 2024 to a low of -$231210.0 in Q1 2026.
• Historically, Deferred Taxes has averaged $217110.0 across 4 years, with a median of $264240.0 in 2024.
• The sharpest annual moves came in 2024 and 2026: Deferred Taxes surged 83.5% in 2024, then slumped 187.5% in 2026.
• A 4-year view of Deferred Taxes shows it stood at $144000.0 in 2023, then soared by 83.5% to $264240.0 in 2024, then changed by 0.0% to $264240.0 in 2025, then plunged by 187.5% to -$231210.0 in 2026.
• The last three Deferred Taxes figures came in at -$231210.0 (Q1 2026), $264240.0 (Q4 2025), and $264240.0 (Q3 2025), per Business Quant data.